Keyword Search
Legend:
CC = Baltimore Convention Center, H = Hilton Baltimore
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Cancer returned 74 record(s)
|
|
Sunday, 07/30/2017
|
Predicting Platinum Resistance in Ovarian Cancer Treatment from Integrated Genomic Data
Esther Drill, Memorial Sloan Kettering Cancer Center; Ronglai Shen, Memorial Sloan Kettering Cancer Center; Yuanjia Wang , Columbia University
2:05 PM
|
Integrative Boosting with Multiple Genomic Platforms Improves Prediction Accuracy for Survival Time in Cancer Patients
Kin Yau Wong, The University of North Carolina at Chapel Hill; Cheng Fan, The University of North Carolina at Chapel Hill; Maki Tanoika , The University of North Carolina at Chapel Hill; Joel S. Parker, The University of North Carolina at Chapel Hill; Andrew B. Nobel, The University of North Carolina at Chapel Hill; Donglin Zeng, University of North Carolina; Danyu Lin, University of North Carolina; Charles M. Perou, The University of North Carolina at Chapel Hill
2:20 PM
|
A Maximum Likelihood Approach for Non-Invasive Cancer Diagnosis Using Methylation Profiling of Cell-Free DNA from Blood
Carol Sun, Oak Park High School; Wenyuan Li, UCLA
2:50 PM
|
Very High Energy Particle-Beam and Gamma Radiation Exposure and Familial Relatedness in Mice
Mark P Little, National Cancer Institute; Pavel Chernyavskiy, National Cancer Institute; Elijah Edmondson, Frederick National Laboratory for Cancer Research; Michael Weil, Colorado State University
3:05 PM
|
Data Sharing for Validation of High-Throughput Chemical Screening Experiments of Cancer Cell Lines
Hongmei Liu, University of Miami; J. Sunil Rao, University of Miami
3:20 PM
|
A Novel Integrative Procedure to Detect Copy Number Aberrations (CNA) in Cancer Cell Free DNA Sequence Data
Hua Huang, University of Wisconsin Milwaukee; Chiang-Ching Huang, University of Wisconsin Milwaukee
4:05 PM
|
Estimation of Hepatocellular Cancer Cytokine Networks While Accounting for Biological Heterogeneity Using Bayesian Edge Regression for Undirected Graphs
Zeya Wang, Rice University; Veera Baladandayuthapani, University of Texas MD Anderson Cancer Center; Wenyi Wang, University of Texas MD Anderson Cancer Center; Jeffrey S. Morris, The University of Texas M.D. Anderson Cancer Center
4:20 PM
|
Evaluating the Statistical Significance of Genomic Lesions in Tumors
Stanley Pounds, St. Jude Children's Research Hospital; Xueyuan Cao, St. Jude Children's Research Hospital; Lei Shi, St. Jude Children's Research Hospital; Wenjian Bi, St. Jude Children's Research Hospital
4:35 PM
|
Data Integration Enhancements to Project Data Sphere's Analytic Capacity and Utility
Steven Cohen, RTI International
4:50 PM
|
Pan-cancer Analysis of Differential DNA Methylation Patterns
Mai Shi, The Chinese University of Hong Kong; Hao Wu, Emory University; Stephen Kwok-Wing Tsui, The Chinese University of Hong Kong; Yingying Wei, The Chinese University of Hong Kong
4:50 PM
|
A Hidden Markov Model for Analyzing Allele-Specific Copy Number Alteration Accounting for Hypersegmentation in Next Generation Sequencing
Hyoyoung Choo-Wosoba, NIH/NCI-DCEG-Biostatistics Branch; Paul S. Albert, National Cancer Institute/NIH; Bin Zhu, NIH/NCI-DCEG-Biostatistics Branch
5:35 PM
|
|
Monday, 07/31/2017
|
Survival Prediction in Early-Stage Lung Cancer via Bayesian Model Averaging of Nonparametric Accelerated Failure Time Models
Kijoeng Nam, Merck; Nicholas Henderson, Johns Hopkins University ; Dai Feng, Merck
|
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades
Sungjin Kim, Cedars-Sinai Medical Center; Marcio Diniz, Cedars Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center
|
Two-Stage Design for Phase II Cancer Clinical Trials with Multiple Endpoints
Hui Gu, Rutgers University; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health; Yaqun Wang, Rutgers; Kejian Liu, Celgene
|
Drug Combination Dose Allocation Using Minimal Sets and Coherence in Partially Ordered Sets in Phase I Cancer Trials
Galen Cook-Wiens, Cedars Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center; Mourad Tighiouart, Cedars-Sinai Medical Center
|
Linear Mixed Effects Model Approach to Analyze Change in Tumor Growth of Colorectal Cancer Mouse Model.
Ramu G Sudhagoni, The University of South Dakota; Khosrow Rezvani, The University of South Dakota; Jessica Freeling, The University of South Dakota
|
Induced Tumor Growth in Rats: Modeling and Estimation
Charles Smith, North Carolina State Univ.; Henry Tuckwell, Monash University
|
Design of Drug Combination Early Phase Cancer Trials Using Time to Toxicity Data
Marcio Diniz, Cedars Sinai Medical Center; José Jimenez, Politecnico di Torino; Andre Rogatko, Cedars Sinai Medical Center; Mourad Tiguiouart, Cedars Sinai Medical Center
|
Bayesian Methods for Image Texture Analysis with Applications to Cancer Radiomics
Xiao Li, University of Texas, School of Public Health, Department of Biostatistics; Michele Guindani, University of California, Irvine; Chaan Ng, The University of Texas MD Anderson C; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
|
Detection of Prostate Cancer with Multi-Parametric MR Imaging Models Utilizing the Anatomic Structure of the Prostate
Jin Jin, University of Minnesota; Joseph Koopmeiners, University of Minnesota; Lin Zhang, University of Minnesota; Greg Metzger, University of Minnesta; Ethan Leng, University of Minnesta
8:35 AM
|
Statistical Models for Cervical Cancer Screening Tests
Keshav Pokhrel, University of Michigan-Dearborn; Vinod Shidham, Wayne State University; Rabita Mahaseth, Wayne State University
9:20 AM
|
Marginal Analysis of Cancer Screening Effect on Mortality Adjusting for Screening Contamination
Sheng Qiu; Alex Tsodikov, University of Michigan
9:20 AM
|
Relationships Between BMI, Alcohol on Liver Cancer
Negasi Beyene, CDC/NCHS
9:35 AM
|
Cancer Phylogenies and Nonparametric Clustering
Jeffrey Miller, Harvard School of Public Health; Scott Carter, Dana-Farber Cancer Institute
9:55 AM
|
Comparing the Mixing Fractions in a Latent Mixture Model to Investigate Change in Mutational Processes During Cancer Growth and Development
Kimberly Siegmund, Univ of Southern California-School of Medicine; Zhi Yang, University of Southern California; Priyatama Pandey, University of Southern California; Paul Marjoram, University of Southern California; Darryl Shibata, University of Southern California
10:55 AM
|
Bayesian Methods for Image Texture Analysis with Applications to Cancer Radiomics
Xiao Li, University of Texas, School of Public Health, Department of Biostatistics; Michele Guindani, University of California, Irvine; Chaan Ng, The University of Texas MD Anderson C; Brian P. Hobbs, The University of Texas MD Anderson Cancer Center
11:20 AM
|
An Integrative Analysis of DNA Methylation and Copy Number Data for Biological Discovery
Jie Chen, Augusta University; Shirong Deng, Augusta University
11:35 AM
|
A Latent Variable Approach to Elicit Continuous Toxicity Scores and Severity Weights for Multiple Toxicities in Dose-Finding Oncology Trials
Nathaniel O'Connell, Medical University of South Carolina; Elizabeth Garrett-Mayer, Medical University of South Carolina
2:05 PM
|
Personalizing Early Detection for Ovarian Cancer with Hierarchical Longitudinal Models of a Blood Biomarker: Experience in Multiple Prospective Screening Trials
Steven Skates, MGH/Biostatistics Center
2:25 PM
|
Cancer Staging in Meta-Analysis by Group Fused Lasso
Wenshuo Liu, University of Wisconsin Madison; Tianjie Wang, University of Wisconsin Madison; Menggang Yu, university of wisconsin-madison
2:35 PM
|
Robust Network-Based Regularization and Variable Selection for High-Dimensional Genomic Data in Cancer Prognosis
Jie Ren, Department of Statistics, Kansas State University; Yinhao Du, Department of Statistics, Kansas State University; Dewey Molenda, Department of Statistics, Kansas State University; Yu Jiang, School of Public Health, University of Memphis; Wu Cen, Department of Statistics, Kansas State University
3:05 PM
|
|
Tuesday, 08/01/2017
|
Inferring Intra-Tumor Heterogeneity by Jointly Modeling Copy Number Aberrations and Somatic Point Mutations
Chong Jin; Wei Sun, Fred Hutchinson Cancer Research Center; Mengjie Chen, Department of Medicine, University of Chicago
|
A Bayesian Approach to Analyzing Gene Expression in Heterogeneous Tissue Samples
Megan Stefanski, University of Missouri - Kansas City; David Spade, University of Missouri - Kansas City
|
Air Quality and Lung Cancer: Analysis via Local Control
Mithun Kumar Acharjee, Lamar University; Kumer Das, Lamar University; S. Stanley Young, CGStat LLC
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
|
A Method for Spatio-Temporal Back-Calculation of Cancer Incidence Rate
Nisheet Nautiyal; Theodore Holford, Yale University
|
Longitudinal regression model for a continuous skewed outcome with zero inflated observations with application to oropharyngeal cancer cost
Ho-Lan Peng; Wenyaw Chan, University of Texas Health Science Center at Houston School of Public Health; Chi-Fang Wu, University of Texas Health Science Center at Houston School of Public Health; Hongyu Miao, University of Texas Health Science Center at Houston School of Public Health; David R Lairson, University of Texas Health Science Center at Houston School of Public Health
|
Estimating and Comparing Cancer Progression Risks Under Varying Surveillance Protocols
Jane Lange, Fred Hutchinson Cancer Research Center; Ruth Etzioni, Fred Hutchinson Cancer Research Center
|
Cumulative vs. Adjacent-Category Logits: Readiness to Quit Smoking Among Cancer Survivors
Zoran Bursac, University of Tennessee Health Science Center; Trish Goedecke, University of Tennessee Health Science Center; Melissa Little, University of Tennessee Health Science Center; Robert Klesges, University of Tennessee Health Science Center
|
Bayesian Mixture Model for Ovarian Cancer Study Using Glycoproteomics and Mass Spectrometry Data
Yulan Liang, University of Maryland; Arpad Kelemen, University of Maryland
|
Semiparametric Regression on Life Lost
Lauren Balmert, University of Pittsburgh; Jong H. Jeong, University of Pittsburgh
8:35 AM
|
Immortal Time Bias in Observational Studies of Time-To-Event Outcomes: Assessing Effects of Post-Mastectomy Radiation Therapy Using National Cancer DataBase (NCDB) Study
Parul Agarwal, Icahn School of Medicine at Mount Sinai; Erin Moshier, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai
8:40 AM
|
A Method for Spatio-Temporal Back-Calculation of Cancer Incidence Rate
Nisheet Nautiyal; Theodore Holford, Yale University
8:45 AM
|
Bayesian Clinical Trial Design for Joint Models of Longitudinal and Survival Data
Joseph G Ibrahim, UNC; Matthew Psioda, UNC Chapel Hill
9:00 AM
|
Development of a Multi-Parametric MR Classifier for Prostate Cancer
Joseph Koopmeiners, University of Minnesota; Jin Jin, University of Minnesota; Lin Zhang, University of Minnesota; Ethan Leng, University of Minnesta; Greg Metzger, University of Minnesta
9:00 AM
|
Longitudinal regression model for a continuous skewed outcome with zero inflated observations with application to oropharyngeal cancer cost
Ho-Lan Peng; Wenyaw Chan, University of Texas Health Science Center at Houston School of Public Health; Chi-Fang Wu, University of Texas Health Science Center at Houston School of Public Health; Hongyu Miao, University of Texas Health Science Center at Houston School of Public Health; David R Lairson, University of Texas Health Science Center at Houston School of Public Health
9:35 AM
|
Estimating and Comparing Cancer Progression Risks Under Varying Surveillance Protocols
Jane Lange, Fred Hutchinson Cancer Research Center; Ruth Etzioni, Fred Hutchinson Cancer Research Center
9:45 AM
|
Estimating lead-time bias in lung cancer diagnosis of patients with prior cancers
Zhiyun Ge, Southern Methodist University & University of Texas Southwestern Medical Center ; Daniel F. Heitjan, Southern Methodist University; Sandi Pruitt, University of Texas Southwestern Medical Center; Lei Xuan , University of Texas Southwestern Medical Center; David Gerber, University of Texas Southwestern Medical Center
9:50 AM
|
Cumulative vs. Adjacent-Category Logits: Readiness to Quit Smoking Among Cancer Survivors
Zoran Bursac, University of Tennessee Health Science Center; Trish Goedecke, University of Tennessee Health Science Center; Melissa Little, University of Tennessee Health Science Center; Robert Klesges, University of Tennessee Health Science Center
10:00 AM
|
Cluster-Enabled Inference for Subgroup Comparison of Copy Number Profiles Using Bayesian Change-Point Models for Profile Characterization
Miranda Lynch, Los Alamos National Laboratory
12:05 PM
|
Patient-Reporting of Symptomatic Toxicities of Cancer Treatment: Current Progress and Emerging Challenges
Sandra Anne Mitchell, National Cancer Institute
2:05 PM
|
Interactive Visualization and Fast Computation of the Solution Path for Convex Clustering and Biclustering
John Nagorski, Rice University; Genevera I. Allen, Rice University
2:55 PM
|
Ensuring Reproducibility of Collaborative Projects: Statisticians Taking the Lead
Rachel Jia, Icahn School of Medicine at Mount Sinai; Madhu Mazumdar, Icahn School of Medicine at Mount Sinai; John Mandeli, Icahn School of Medicine at Mount Sinai; Meng Ru, Icahn School of Medicine at Mount Sinai
3:05 PM
|
Statistical Methods to Analyze PRO-CTCAE Data in Oncology Clinical Trials
Amylou Dueck, Mayo Clinic
3:05 PM
|
Mixture Models for Left- and Interval-Censored Data: Applications to a Cancer Screening Cohort Assembled from Electronic Health Records
Li Cheung, National Cancer Institute; Qing Pan, George Washington University; Noorie Hyun, National Cancer Institute; Mark Schiffman, National Cancer Institute; Barbara Fetterman, Kaiser Permanente Northern California; Philip Castle, Albert Einstein School of Medicine; Thomas Lorey, Kaiser Permanente Northern California; Hormuzd Katki, National Cancer Institute
3:20 PM
|
Dimension Reduction in the Study of Etiologic Heterogeneity
Emily Zabor, Memorial Sloan Kettering Cancer Center; Colin Begg, Memorial Sloan Kettering Cancer Center
3:35 PM
|
|
Wednesday, 08/02/2017
|
The Prostate Biopsy Collaborative Group
Katharina Selig, Technical University of Munich; Johanna Straubinger, Technical University of Munich; Donna Ankerst , Technical University of Munich
|
Clinical Trials Start up Process
Yi Zhong; Dinesh Mudaranthakam, Department of Biostatistics, University of Kansas Medical Center; Byron Gajewski, Department of Biostatistics, University of Kansas Medical Center; Kevin Smilor, 2. Division of Clinical Research Administration, University of Kansas Medical Center; Karen Blackwell, Human Research Protection Program, University of Kansas Medical Center
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
|
Regulation of Cancer Testis Antigen Rich Whole Transcriptome Profiling of Ovarian Tumors
Kevin H Eng, Roswell Park Cancer Institute; Wenjun He, Roswell Park Cancer Institute; Kayla Morrell, Roswell Park Cancer Institute; Anthony Milliotto, Roswell Park Cancer Institute; Kunle Odunsi, Roswell Park Cancer Institute
8:35 AM
|
Subgroup Analysis of Censored Survival Data on Cancer Treatment
Qing Zhang, Stony Brook University; Hongshik Ahn, Stony Brook University
9:10 AM
|
It's All About the Residuals: Estimating Gene Networks by Leveraging Residual Structure in Multi-Tissue Transcriptomic Data
Matthew McCall, University of Rochester Medical Center
9:35 AM
|
Approaches to Analysis of Treatment Interruptions Among Cancer Patients on Oral Oncolytic Agents
Asish Banik, Michigan State University; Charles W. Given, Michigan State University; Barbara Given, Michigan State University; Atreyee Majumder, Michigan State University; Alla Sikorskii, University of Arizona ; Eric Vachon, Michigan State University
10:35 AM
|
A Study of Some Alternative Statistical Methods for the Characterization of Tumor Risk Based on PET Imaging Data
Eric Wolsztynski, University College Cork; Tian Mou, University College Cork; Mark Muzi, UW-Radiology, Neurology & RadOnc; Finbarr O'Sullivan, University College Cork
10:35 AM
|
Model-based Design for the Early Development of Cancer Immunotherapy Combinations
Nolan Wages, University of Virgina
11:35 AM
|
Statistical Methods to Asses Cancer Immune Microenvironment to Identify Biomarkers for Cancer Immunotherapy
Wei Sun, Fred Hutchinson Cancer Research Center
2:05 PM
|
Preliminary Test Estimation and Shrinkage Estimation for Reduced Rank Regression in Cancer Epidemiology Studies
Jaya Satagopan, Memorial Sloan Kettering Cancer Center
3:05 PM
|
Accounting for Tumor Purity Improves Cancer Subtype Classification from DNA Methylation Data
Hao Wu, Emory University
3:20 PM
|
|
Thursday, 08/03/2017
|
Design of Phase I/II Drug Combination Cancer Trials Using CRM and Adaptive Randomization
Mourad Tighiouart, Cedars-Sinai Medical Center; Matthieu Clertant, Cedars-Sinai Medical Center
9:20 AM
|
Analyzing Mortality Following Breast Cancer Diagnosis in Louisiana SEER Data via a Spatial Accelerated Failure Time Model
Shanshan Zhao, National Institute of Environmental Health Sciences; Rachel Carroll, National Institute of Environmental Health Sciences; Andrew Lawson, Department of Public Health Sciences, Medical University of South Carolina
10:35 AM
|
A Robust Paradigm of Finding the Maximum Tolerated Dose in Phase I Cancer Clinical Trials
Tina Young, Bristol-Myers Squibb; Dirk Moore, Rutgers School of Public Health; Yong Lin, Rutgers; Weichung Joe Shih, Rutgers School of Public Health
10:50 AM
|
Calibration and Seasonal Adjustment for Matched Case-Control Studies of Vitamin D and Cancer
Mitchell Gail , National Cancer Institute, NIH, HHS; Jincao Wu, Food and Drug Administration; Molin Wang, Harvard T. H. Chan School of Public Health and Channing Division of Network Medicine; Shiaw-Shyuan Yaun, Harvard T. H. Chan School of Public Health; Nancy R. Cook, Harvard T. H. Chan School of Public Health; A. Heather Eliassen, Harvard T. H. Chan School of Public Health; Marjorie L McCullough, American Cancer Society; Kai Yu, National Cancer Institute; Anne Zeleniuch-Jacquotte, New York University School of Medicine; Stephanie A. Smith-Warner, Harvard T. H. Chan School of Public Health; Regina G. Ziegler, National Cancer Institute; Raymond Carroll, Texas A&M University
11:20 AM
|
A Two-Stage, Phase II Clinical Trial Design with Nested Criteria for Early Stopping and Efficacy
Michelle DeVeaux, Yale University; Daniel Zelterman, Yale University; Michael Kane, Yale University
11:20 AM
|
Constructing a Synthetic Control Arm from Previous Clinical Trials, with Application to Cancer Trials
Steven Schwager, Medidata Solutions; Michael Elashoff, Medidata Solutions; Philip Beineke, Medidata Solutions; Ruthanna Davi, Medidata Solutions
11:50 AM
|
|
|
